On 20^th May 2022, Prof. Karen Anderson and Prof. Jennifer M Blain Christen of Arizona State University, USA visited Translational Health Science and Technology Institute (THSTI). They delivered keynote lectures and interacted with the faculty and scientists of THSTI. Prof Anderson spoke in detail about T Cell cancer vaccines using human leukocyte antigens (HLAs) as epitopes. She discussed her work on Human papilloma virus (HPV) as an oncogenic immune target. Prof Christen shared her work on affordable, robust and sensitive serological lateral flow immunoassay diagnostics. She also gave insights into her recent work on developing rapid COVID-19 saliva test. Post the lectures, Prof. Anderson and Prof. Chirsten had one on one interaction with the researchers from Infection and Immunology (I&I) and Multidisciplinary Clinical and Translational Research (MCTR), respectively.